KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — KEQU

Balance Sheet

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	8.15	12.59	19.49	9.45	25.96	24.21	21.31	13.72	12.70	13.05	9.42	14.36	4.70	4.72	4.99	5.56	5.76	3.99
Accounts Receivable	54.13	59.02	56.90	57.42	41.89	43.55	41.11	42.60	42.46	43.99	41.47	40.71	35.05	37.07	34.93	30.09	33.75	30.90
Inventory	32.91	35.50	34.92	31.56	18.66	19.29	21.85	21.67	22.13	21.41	24.50	25.10	19.95	18.12	17.85	15.62	16.12	16.46
Total Current Assets	103.58	113.64	117.15	108.61	96.44	92.70	96.16	90.88	93.52	91.56	90.61	97.78	68.92	66.82	61.97	60.12	62.39	58.48
Property, Plant & Equipment	22.61	23.16	22.78	23.85	16.99	17.11	17.49	17.83	17.34	14.54	14.61	14.79	15.35	15.52	15.77	16.21	16.22	16.51
Goodwill	12.49	12.49	12.49	14.15	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Intangible Assets	11.78	12.16	12.55	13.32	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Non-current Assets*	72.38	75.44	76.34	80.54	38.04	39.32	30.15	30.83	31.30	30.23	28.50	27.86	26.77	27.47	28.33	29.49	28.97	28.70
Total Assets	175.96	189.08	193.49	189.15	134.48	132.02	126.31	121.71	124.82	121.79	119.12	125.64	95.69	94.29	90.30	89.61	91.36	87.18
Accounts Payable	23.64	22.66	26.33	24.53	21.46	20.62	19.08	19.17	22.14	24.91	23.05	25.04	27.42	20.23	17.49	16.00	17.26	14.09
Total Current Liabilities	48.79	45.81	50.49	50.17	36.47	36.69	42.14	38.73	44.23	44.21	42.86	49.52	47.51	43.77	36.26	31.61	33.86	30.66
Long-term Debt	21.33	35.25	37.38	37.96	--	--	--	--	--	--	--	0.00	--	--	--	--	--	--
Total Non-current Liabilities*	54.65	71.55	74.13	76.86	37.35	37.82	38.82	39.56	40.05	41.24	41.25	40.94	12.00	13.22	13.70	19.73	19.43	18.34
Total Liabilities	103.43	117.36	124.62	127.03	73.82	74.51	80.96	78.29	84.28	85.45	84.11	90.46	59.51	56.99	49.96	51.35	53.29	49.00
Retained Earnings	65.15	64.46	62.01	54.07	52.72	49.71	36.49	33.97	31.24	27.76	27.03	27.28	28.39	29.70	32.80	37.12	37.04	37.22
Total Stockholder Equity	70.68	69.85	67.08	60.80	59.33	56.02	44.08	42.11	39.43	35.35	34.40	34.69	35.85	37.01	40.06	38.06	37.83	37.90

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Total Revenue	71.40	69.40	70.10	71.10	77.15	67.17	47.76	48.39	56.70	46.78	50.44	49.84	53.99	60.82	54.56	50.12	49.72	40.63	39.03	39.49
Cost of Revenue	50.16	50.85	50.38	50.17	53.11	48.79	33.81	35.91	42.06	34.75	36.97	37.92	43.63	50.49	45.86	43.93	40.39	35.01	35.43	33.82
Gross Profit	21.25	18.55	19.72	20.93	24.04	18.38	13.95	12.49	14.64	12.03	13.47	11.91	10.36	10.33	8.70	6.20	9.33	5.62	3.60	5.67
Total Operating Expenses	16.03	15.96	15.61	16.12	15.54	16.13	9.52	9.91	9.08	8.22	8.36	8.11	7.66	8.03	7.95	6.59	7.09	6.49	6.49	6.77
Operating Income	5.22	2.58	4.11	4.81	8.50	2.25	4.43	2.58	5.56	3.81	5.11	3.81	2.70	2.30	0.76	(0.40)	2.24	(0.87)	(2.89)	(1.09)
Interest Expense	--	--	--	1.06	--	1.14	0.44	0.47	0.59	0.41	0.37	0.43	0.54	0.44	0.37	0.38	0.24	0.16	0.13	0.11
Pretax Income	4.76	1.60	3.45	3.92	7.15	1.27	3.93	2.43	1.35	3.52	4.85	3.41	2.32	2.06	0.46	(0.34)	2.35	(0.89)	(2.89)	(1.06)
Tax Provision	1.06	0.53	0.92	0.76	2.20	(0.11)	0.92	0.19	(9.83)	0.98	2.02	0.90	1.23	0.96	0.57	0.38	2.67	0.40	0.20	0.25
Net Income	3.39	0.69	2.44	3.09	4.85	1.35	3.01	2.19	11.03	2.52	2.73	2.47	1.00	0.72	(0.24)	(0.75)	(0.36)	(1.32)	(3.10)	(1.34)
Basic EPS	1.19	0.24	0.85	1.08	1.69	0.47	1.05	0.77	3.83	0.87	0.94	0.87	0.36	0.26	(0.09)	(0.27)	(0.14)	(0.47)	(1.11)	(0.48)
Diluted EPS	1.13	0.23	0.82	1.04	1.63	0.45	1.01	0.74	3.74	0.85	0.93	0.86	0.36	0.25	(0.09)	(0.27)	(0.14)	(0.47)	(1.11)	(0.48)

Cash Flow Statement

(in millions USD)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Operating Cash Flow	5.46	11.65	(4.26)	5.79	9.41	(2.27)	8.44	(0.79)	1.15	9.50	0.75	8.17	(0.24)	(2.96)	(4.27)	3.69	(6.80)	4.98	(4.29)	(1.78)
Capital Expenditures	0.93	0.67	1.57	0.77	0.52	1.65	0.96	0.28	0.98	0.48	1.26	1.65	2.59	0.64	0.53	0.39	0.69	0.29	0.45	0.48
Free Cash Flow*	4.53	10.98	(5.83)	5.02	8.89	(3.92)	7.48	(1.07)	0.17	9.03	(0.52)	6.52	(2.83)	(3.60)	(4.80)	3.30	(7.48)	4.69	(4.74)	(2.26)
Investing Cash Flow	(0.93)	(0.67)	(1.57)	(0.77)	(0.52)	(29.42)	(0.68)	(0.28)	(0.98)	(0.47)	(1.26)	(1.65)	(2.59)	(0.64)	(0.53)	(0.39)	(0.69)	(0.29)	(0.45)	(0.48)
Financing Cash Flow	(2.95)	(14.06)	(0.85)	(1.46)	(4.34)	14.64	(3.23)	0.34	(1.47)	(3.63)	0.78	1.31	(2.16)	5.56	(0.14)	11.67	8.91	(4.74)	4.84	2.02

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q4 2020	Q2 2020	Q1 2020	Q3 2019	Q4 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016	Q4 2015	Q3 2015	Q2 2015	Q1 2015	Q4 2014
Dividends Per Share	0.19	0.19	0.19	0.17	0.17	0.19	0.15	0.15	0.15	0.15	0.13	0.13	0.13	0.13	0.12	0.12	0.12	0.23	0.11	0.12